FDA-approved GLP-1 pill offers cheaper, needle-free option for weight loss
KENT COUNTY, Mich. — A new oral version of the weight loss drug Wegovy has been approved by…
SuppCo launches certification to verify actives in dietary supplements
The new program complements SuppCo’s TrustScore supplement quality rating system and builds on earlier testing initiatives, which revealed…
Pfizer’s Braftovi Combo Wins FDA Approval
The U.S. Food and Drug Administration has granted full approval to Pfizer’s BRAFTOVI (encorafenib) in combination with cetuximab and fluorouracil-based chemotherapy…
Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals – Endpoints News
Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals Endpoints NewsCompass Pathways to Announce New…
GSK gets FDA approval for Exdensur asthma treatment
Key Terms
eosinophilic phenotype
medical
An eosinophilic phenotype…
Milestone Pharma gets FDA approval for first PSVT nasal spray
Milestone (Nasdaq: MIST) announced FDA approval of CARDAMYST (etripamil) nasal spray for conversion…
Orion Pharma: Building tomorrow’s healthcare
There’s something compelling about pharmaceuticals, the business is never merely business. It directly impacts human health, affects families,…
Stealth BioTherapeutics Announces FDA Accelerated Approval of FORZINITY™ (elamipretide HCl), the First Therapy for Progressive and Life-limiting Ultra-rare Genetic Disease Barth Syndrome
NEEDHAM, Mass., Sept. 19, 2025 /PRNewswire/ — Stealth BioTherapeutics Inc. (the “Company” or “Stealth”), a commercial-stage biotechnology company focused…